DELTA FINANCIAL ADVISORS LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1790295
Metairie, LA
Position in VRTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$428,677
+$43,313 QoQ
Shares Held
863
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,117
of 1,735 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DELTA FINANCIAL ADVISORS LLC holds $1,309,739 across 2 Biotechnology names. VRTX ranks #2 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,413 | $881,062 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
863 | $428,677 |
All Filings in VRTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $428,677 | 863 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $385,364 | 863 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $395,329 | 872 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $319,578 | 816 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $350,817 | 788 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $330,647 | 682 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $262,157 | 651 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $296,721 | 638 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $289,668 | 618 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $258,330 | 618 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $245,354 | 603 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $209,687 | 603 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $212,201 | 603 | Shares | Sole | 2023-08-03 | |
| No filing history on record for this holder in this stock. | ||||||